Shanghai Yizhong Pharmaceutical Co Ltd (688091) — Capital Reinvestment Ratio
Shanghai Yizhong Pharmaceutical Co Ltd (688091) has a Capital Reinvestment Ratio of 1.44x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥21.03 Million) in capital expenditures (CN¥30.36 Million). Check 688091 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai Yizhong Pharmaceutical Co Ltd Capital Reinvestment Ratio (2022–2024)
This chart tracks Shanghai Yizhong Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see Shanghai Yizhong Pharmaceutical Co Ltd (688091) cash flow conversion.
Annual Capital Reinvestment Ratio for Shanghai Yizhong Pharmaceutical Co Ltd (2022–2024)
Year-by-year Capital Reinvestment Ratio for Shanghai Yizhong Pharmaceutical Co Ltd from 2022 to 2024. See 688091 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.03x | CN¥39.44 Million | CN¥80.04 Million | ▲ +1900.3% |
| 2023 | 0.10x | CN¥86.55 Million | CN¥8.78 Million | ▼ -68.7% |
| 2022 | 0.32x | CN¥110.78 Million | CN¥35.88 Million | — |